Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q4 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Morgan Stanley Starts Amplifon SpA (AMP:IM) (AMFPF) at Overweight
• UBS Upgrades Zhejiang Leapmotor Technology (9863:HK) to Buy
• UBS Assumes Ayala Land, Inc (ALI:PM) (AYAAF) at Buy